Literature DB >> 23873179

Polymorphisms in the genes related to angiogenesis are associated with uterine cervical cancer.

Christian Ramos-Flores1, Teresa Romero-Gutiérrez, Iván Delgado-Enciso, Gabriela Enríquez Maldonado, Víctor Montaño Plascencia, Oscar F Vazquez-Vuelvas, Antonio Quintero-Ramos, Roberto Chaparro Mejía, Francisco Espinoza-Gomez, Luz M Baltazar-Rodriguez, Laura L Valdez-Velazquez.   

Abstract

INTRODUCTION: The expression of plasminogen activator inhibitor type 1 (PAI-1), vascular endothelial growth factor (VEGF), and transforming growth factor β1 (TGF-β1) participates in the angiogenesis of several cancer types. The goal of this study was to investigate polymorphisms in genes related to angiogenesis (PAI-1-675 4G/5G, VEGF C936T, and TGF-β1 G-800A) to evaluate the risk for developing uterine cervical cancer (UCC).
METHODS: In a case-control study, 100 healthy subjects and 100 patients with UCC from Mexico were included. We determined the genetic profile of the polymorphic markers, which were evaluated by polymerase chain reaction using a sequence-specific primer.
RESULTS: There was no statistical difference in the allele distribution from the intergroup comparisons of PAI-1 675 4G/5G and VEGF C936T data; however, a significant difference was observed within TGF-β1 G-800A. The linkage disequilibrium analysis revealed that PAI-1 -675 4G and TGF-β1 -800A pair-haplotype was in strong linkage disequilibrium with a significantly increased risk (odds ratio, 3.44; 95% confidence interval, 1.66-7.25) to UCC.
CONCLUSIONS: The polymorphisms in the genes related to angiogenesis -675 4G/5G PAI-1 and G-800A TGF-β1, segregated solely or combined, might contribute to the increased susceptibility to UCC in a Mexican population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873179     DOI: 10.1097/IGC.0b013e31829f4c6f

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

Review 1.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

2.  Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.

Authors:  K Torres-Poveda; A I Burguete-García; M Bahena-Román; R Méndez-Martínez; M A Zurita-Díaz; G López-Estrada; K Delgado-Romero; O Peralta-Zaragoza; V H Bermúdez-Morales; D Cantú; A García-Carrancá; V Madrid-Marina
Journal:  BMC Cancer       Date:  2016-05-24       Impact factor: 4.430

3.  PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.

Authors:  Jiaxi Wang; Yuanyuan Peng; Hejia Guo; Cuiping Li
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.